πŸ‡ΊπŸ‡Έ FDA
Patent

US 9546218

Anti-Tie2 antibodies and uses thereof

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 9546218 (Anti-Tie2 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39533, A61K39/3955